Massy, Île-de-France, France
Product & Innovation Executive in MedTech, with a strong track record in surgical and implantable medical devices, spanning hernia repair, neurovascular and oncology applications. Currently Program Director and Core Team Lead for Medtronic’s Hernia Mesh Portfolio, I lead product strategy and cross-functional execution of new medical devices in highly regulated environments (Class III, MDR), from early concept through clinical readiness and early commercialization. Previously Chief Innovation Officer at Sensome, I combined deep technology leadership with business strategy, securing non-dilutive funding (BPI, EIC), expanding clinical indications through KOL engagement, and structuring innovation pipelines to maximize long-term company value. My background bridges product strategy and executive leadership, with a clear focus on transforming complex technologies into clinically impactful, commercially successful medical products.
Product owner and strategic lead for Medtronic’s hernia mesh portfolio, with responsibility for cross-functional execution from concept to early commercialization, new product strategy, pipeline prioritization.
- Led successful non-diluitive funding initiatives with BPI and EIC, securing crucial financial support for innovative projects. - Established key opinion leader (KOL) connections to explore new indications in lung oncology and peripheral vascular diseases. - Continuously led and coordinated pre-clinical activities, ensuring alignment with strategic objectives and regulatory requirements. - Drove innovation and strategic development to expand Sensome's portfolio and address emerging medical needs. - Fostered collaborative partnerships with academic and hospital institutions to advance cutting-edge research and development. - Define organizational optimization by setting up a holding structure to maximize Sensome's value.
- Established international research programs with renowned hospitals worldwide for neurovascular treatment, including Mayo Clinic, Grady Memorial Hospital, and Toronto Western Hospital in North America; Kobe Medical Center in Japan; Purpan and Bicêtre Hospitals in France; Vall d'Hebron in Spain; and the Clinical Center of Serbia in Belgrade. - Primary and secondary market studies to expand Sensome's technology portfolio and development of new scientific research programs for technology leadership.
- Developed the risk management process at Sensome from scratch, ensuring compliance with ISO 14971 and ISO 13485 standards. - Conducted comprehensive functional analyses and with cross-functional teams (comprising engineers, clinical staff, physicians). - Defined and analyzed risks for Class III medical devices, facilitating rigorous risk assessment and mitigation strategies. - Implemented continuous improvements in the risk management process, enhancing overall product safety and quality. Project leader for national and international research projects in collaboration with renowned hospitals and universities in the fields of neurovascular and oncology.
- Evaluation of MedFIT Pitch Sessions - Warm-Up Sessions for Selected Pitchers
Development of the first impedance-based technology sensor (patented) to be integrated in a new Smart neurovascular guidewire.
Design and development of an electrochemical system to investigate cell penetrating peptides vectorisation (carriers of drugs, nanoparticles, nanodots, etc.) through an artificial cell membrane by impedance spectroscopy and elelctrochemical noise.